Despite the FDA announcement that it will delay the active enforcement date of the DSCSA by a year, companies who have yet to start implementing a solution are still facing an uphill battle to compliance.

In this industry roundtable with Pharmaceutical Processing, Dexter Tjoa, director of corporate strategy at Tjoapack discusses the biggest concerns for the healthcare industry and the pressures that the new serialization legislation is placing on the sector.

Read the full roundtable here: https://www.pharmpro.com/article/2017/11/biggest-trends-pharma

Despite the FDA announcement that it will delay the active enforcement date of the DSCSA by a year, companies who have yet to start implementing a solution are still facing an uphill battle to compliance.

In this industry roundtable with Pharmaceutical Processing, Dexter Tjoa, director of corporate strategy at Tjoapack discusses the biggest concerns for the healthcare industry and the pressures that the new serialization legislation is placing on the sector.

Read the full roundtable here: https://www.pharmpro.com/article/2017/11/biggest-trends-pharma

To continue reeading fill in the form below:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Ready to shape the future of your pharmaceutical supply chain?